KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $60.9 million.

  • Evolent Health's Accumulated Expenses fell 4944.71% to $60.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.9 million, marking a year-over-year decrease of 4944.71%. This contributed to the annual value of $66.4 million for FY2024, which is 5571.48% down from last year.
  • Evolent Health's Accumulated Expenses amounted to $60.9 million in Q3 2025, which was down 4944.71% from $63.9 million recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Accumulated Expenses peaked at $194.0 million during Q3 2023, and registered a low of $52.3 million during Q2 2021.
  • Its 5-year average for Accumulated Expenses is $108.0 million, with a median of $107.2 million in 2021.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 13709.61% in 2022, then crashed by 5571.48% in 2024.
  • Evolent Health's Accumulated Expenses (Quarter) stood at $107.2 million in 2021, then grew by 3.69% to $111.2 million in 2022, then surged by 34.76% to $149.8 million in 2023, then crashed by 55.71% to $66.4 million in 2024, then dropped by 8.24% to $60.9 million in 2025.
  • Its Accumulated Expenses was $60.9 million in Q3 2025, compared to $63.9 million in Q2 2025 and $99.5 million in Q1 2025.